Drugs News and Research

RSS

Counterfeit pharmaceutical products: Practicable and entirely detectable identification with RFID

A detailed product proof and improved security against counterfeiting pharmaceutical products become more and more important, especially nowadays when customers can order their drugs online. The legislative pressure increases primarily for reasons of patient safety, incorrect medications, and drug counterfeiting.

1 Apr 2010

Major breakthrough may help develop low toxicity drugs for sleeping sickness

Scientists from the Drug Discovery Unit at the University of Dundee - working together with partners at the University of York and the Structural Genomics Consortium in Toronto - have made a major breakthrough in identifying new treatments for a fatal disease which infects tens of thousands of Africans each year.

1 Apr 2010

TCA may be an effective treatment option for patients who suffer from PVOD

Traditional Chinese acupuncture, where very thin needles are used to stimulate specific points in the body to elicit beneficial therapeutic responses, may be an effective treatment option for patients who suffer from persistent post- viral olfactory dysfunction, according to new research in the April 2010 issue of Otolaryngology - Head and Neck Surgery.

1 Apr 2010

Cell study may yield new treatment strategies for debilitating diseases

A Los Alamos National Laboratory toxicologist and a multidisciplinary team of researchers have documented potential cellular damage from "fullerenes"-soccer-ball-shaped, cage-like molecules composed of 60 carbon atoms. The team also noted that this particular type of damage might hold hope for treatment of Parkinson's disease, Alzheimer's disease, or even cancer.

1 Apr 2010

States face health care budget cuts, seek health-related legislation

Parents, caregivers and advocates joined hospital executives and legislators Tuesday to complain about the potential impact of [Louisiana] Gov. Bobby Jindal's proposed budget cuts and privatization initiatives on Louisiana's most vulnerable residents.

1 Apr 2010

Crack, cocaine usage increases risk of HIV in adolescents

Teens with a history of crack or cocaine use are significantly more likely to engage in unprotected sex than youth who have never used these drugs, putting themselves at increased risk for HIV, according to a study in the April issue of the Journal of Child and Adolescent Substance Abuse.

1 Apr 2010

Dutasteride reduces risk of prostate cancer

There is good news for those at high risk for prostate cancer. The drug dutasteride which is manufactured by GlaxoSmithKline as the drug Avodart, has been found to reduce the risk of prostate cancer by a quarter. The drug is at present being used to treat enlarged prostates.

1 Apr 2010

FDA clears AdvanDx' 90 minutes protocol for C. albicans PNA FISH and C. albicans/C. glabrata PNA FISH tests

AdvanDx today announced that it has received FDA 510(k) clearance for a fast, 90 minutes protocol for its C. albicans PNA FISH® and C. albicans/C. glabrata PNA FISH® tests. The faster protocol reduces the PNA FISH turn-around time from the original 2.5 hours to 90 minutes by reducing PNA probe hybridization from 90 minutes to 30 minutes.

31 Mar 2010

MIPA launches campaign to educate consumers save money on prescription medications

The Massachusetts Independent Pharmacists Association today announced the kickoff of a campaign aimed at educating consumers about a proposal to help save money on prescription medications. MIPA was joined by patient groups, pharmacists, and lawmakers at a Boston pharmacy, Tremont Drug, to highlight the fact that Massachusetts is the only state in the nation that bans the use of manufacturer discounts and co-pay assistance programs for the purchase of prescription drugs.

31 Mar 2010

Nation's emergency physicians warn parents about dangers of prescription drug abuse

The nation's emergency physicians are issuing a strong warning to parents about the dangers of prescription drug abuse, which are now the second most abused drugs, after marijuana. Nearly three-quarters of a million people (741,425) needed emergency care in 2006 because of prescription drug abuse.

31 Mar 2010

2010 BIO International Convention to discuss issues that impact drug discovery and development

The 2010 BIO International Convention will feature a robust health and medical program highlighting the latest scientific breakthroughs and policy and business development issues that impact drug discovery and development. Hosted by the Biotechnology Industry Organization, the Convention will be held May 3-6, 2010 in Chicago, Ill. at McCormick Place.

31 Mar 2010

New legislation will increase access to health care, says DDI

Will the newly signed health care legislation create a major shift in how pharmaceutical brand decisions are made? The bill will increase access to health insurance, but many believe the practice of medicine is already in transition, and the bill signed by President Obama will simply accelerate changes already being implemented.

31 Mar 2010

GSK, Isis Pharmaceuticals collaborate to develop new therapeutics for rare and serious disease

GlaxoSmithKline and Isis Pharmaceuticals, Inc. announced today a new strategic alliance that will apply the Isis antisense drug discovery platform to seek out and develop new therapeutics against targets for rare and serious disease, including infectious diseases and some conditions causing blindness.

31 Mar 2010

PhRMA report: 234 medicines in development for special health care needs of children

America's pharmaceutical research and biotechnology companies are developing 234 medicines for the special health care needs of children, according to a new report released today by the Pharmaceutical Research and Manufacturers of America.

31 Mar 2010

Ampio Pharmaceuticals receives approval to trade under new stock trading symbol "AMPE"

Ampio Pharmaceuticals, Inc., announced it has received approval for a new stock trading symbol from FINRA Operations. Effective March 31, 2010, Ampio Pharmaceuticals, Inc. will trade under the symbol "AMPE," and Ampio's common stock will carry a new CUSIP number, 03209T 109. The symbol change follows the March 24 change in the company's corporate name from Chay Enterprises, Inc. to Ampio Pharmaceuticals, Inc., and its reincorporation in Delaware.

31 Mar 2010

Bright light therapy box for SAD, depression, bipolar disorder and sleep problems

Alaska Northern Lights manufactures a bright light therapy box that aids in treating chronic health problems such as seasonal affective disorder (SAD), depression, bipolar disorder and sleep problems. Sufferers of SAD, a form of clinical depression, include up to 25 percent of those living in northern latitudes who experience varying degrees of SAD during winter months when there is less natural light. Night shift workers are also susceptible to SAD which affects over one third of the population, or about 10.8 million Americans.

31 Mar 2010

Consumers should spring clean their medicine cabinets to prevent potential potency problems

MediNurse, now in its 25th year and the premier provider of private duty services and corporate wellness programs, reminds the public that spring cleaning is important for the medicines in your home.

31 Mar 2010

Novel oral anticoagulants to drive venous thromboembolism drug market to $5 billion in 2018

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the launches and widespread uptake of novel oral anticoagulants will drive the venous thromboembolism drug market to nearly double from $2.9 billion in 2008 to more than $5 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

31 Mar 2010

AAN awards Cedars-Sinai researcher 2010 Sheila Essey Award for ALS research

The American Academy of Neurology (AAN) is awarding the 2010 Sheila Essey Award-An Award for ALS Research to Clive Svendsen, PhD, with the Cedars-Sinai Regenerative Medicine Institute in Los Angeles, CA. Svendsen will receive the award during the AAN's 62nd Annual Meeting in Toronto, held April 10 through April 17, 2010.

31 Mar 2010

New anti-inflammatory drug shows promise for treating inflammatory disorders

Aspirin, ibuprofen and other non-steroidal anti-inflammatory drugs (NSAIDs) remain the most common treatment to relieve symptoms of arthritis and other inflammatory disorders. But despite their widespread use (around 2.5 million Canadians have osteoarthritis) these medications are also known to cause severe, sometimes life-threatening adverse effects within the body, particularly in the gastrointestinal tract

31 Mar 2010

Drugs News and Research

Counterfeit pharmaceutical products: Practicable and entirely detectable identification with RFID

Major breakthrough may help develop low toxicity drugs for sleeping sickness

TCA may be an effective treatment option for patients who suffer from PVOD

Cell study may yield new treatment strategies for debilitating diseases

States face health care budget cuts, seek health-related legislation

Crack, cocaine usage increases risk of HIV in adolescents

Dutasteride reduces risk of prostate cancer

FDA clears AdvanDx' 90 minutes protocol for C. albicans PNA FISH and C. albicans/C. glabrata PNA FISH tests

MIPA launches campaign to educate consumers save money on prescription medications

Nation's emergency physicians warn parents about dangers of prescription drug abuse

2010 BIO International Convention to discuss issues that impact drug discovery and development

New legislation will increase access to health care, says DDI

GSK, Isis Pharmaceuticals collaborate to develop new therapeutics for rare and serious disease

PhRMA report: 234 medicines in development for special health care needs of children

Ampio Pharmaceuticals receives approval to trade under new stock trading symbol "AMPE"

Bright light therapy box for SAD, depression, bipolar disorder and sleep problems

Consumers should spring clean their medicine cabinets to prevent potential potency problems

Novel oral anticoagulants to drive venous thromboembolism drug market to $5 billion in 2018

AAN awards Cedars-Sinai researcher 2010 Sheila Essey Award for ALS research

New anti-inflammatory drug shows promise for treating inflammatory disorders

Drug Discovery - Second Edition eBook

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News